# MoonLake Immunotherapeutics: Form 8-K, filed Jun 1, 2026

- Company: [MoonLake Immunotherapeutics](/companies/mltx.md) (CIK 1821586)
- Form: 8-K
- Filed: 2026-06-01
- Accepted by EDGAR: Jun 1, 2026, 06:20 ET
- Period: 2026-05-22
- Accession: 0001213900-26-063125
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1821586/000121390026063125/ea0292693-8k_moonlake.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1821586/000121390026063125/

## Items reported

- Item 1.01: Entry into a material agreement

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1821586/000121390026063125/ea0292693-8k_moonlake.htm

Filed Jun 1, 2026.
Source: SEC EDGAR, the filing index for accession 0001213900-26-063125. Last ingested by Listed: Nov 4, 2026, 07:34 ET. No prices; not investment advice.